Monoaminergic modulation of cortical and thalamic inputs to the dorsal striatum (DS) is crucial for reward-based learning and action control. While dopamine has been extensively investigated in this context, the synaptic effects of serotonin (5-HT) have been largely unexplored. Here, we investigated how serotonergic signaling affects associative plasticity at glutamatergic synapses on the striatal projection neurons of the direct pathway (dSPNs). Combining chemogenetic and optogenetic approaches reveals that impeding serotonergic signaling preferentially gates spike-timing-dependent long-term depression (t-LTD) at thalamostriatal synapses. This t-LTD requires dampened activity of the 5-HT4 receptor subtype, which we demonstrate controls dendritic Ca 2+ signals by regulating BK channel activity, and which preferentially localizes at the dendritic shaft. The synaptic effects of 5-HT signaling at thalamostriatal inputs provide insights into how changes in serotonergic levels associated with behavioral states or pathology affect striataldependent processes.
INTRODUCTION
The dorsal striatum (DS) of the basal ganglia (BG) plays a critical role in voluntary movement, learning, and motivation. It also represents the primary site of dysfunction in psychomotor diseases such as Parkinson's disease (PD), drug addiction, and obsessive-compulsive disorders (OCDs). The DS receives glutamatergic excitatory inputs from the cortex and thalamus. These inputs converge on striatal projection neurons (SPNs) of the direct (dSPN) and indirect (iSPN) pathways, which exert opposing control over motor output and hedonic states. While dSPNs stimulate movement, reinforcement, and reward, iSPNs inhibit movement and mediate punishment and aversion (Kravitz et al., 2010 (Kravitz et al., , 2012 Tecuapetla et al., 2016; Vicente et al., 2016) .
It is increasingly clear that encoding of action selection at striatal circuits requires regulation of SPN activity and plasticity (Kravitz et al., 2012; O'Hare et al., 2016; Sippy et al., 2015) . While the neuromodulatory signaling mechanisms controlling iSPN synaptic plasticity, especially long-term-depression (LTD), have been studied extensively, identifying parallel mechanisms in dSPNs has proven more difficult (Zhai et al., 2018) . One of the most important neuromodulatory inputs to the striatum is dense dopaminergic innervation from the substantia nigra (Tritsch and Sabatini, 2012) . In particular, dSPNs expressing the Gs-coupled D1 dopamine (DA) receptors (D1R) are stimulated by dopaminergic signaling. In the presence of behaviorally relevant stimuli, DA is thought to reinforce motor actions that result in reward outcomes through the potentiation of corticostriatal synapses formed on dSPNs. Recent evidence indicates that DA depletion specifically weakens thalamic connections to dSPNs, but not to cortical afferents to these neurons (Parker et al., 2016) . This weakening, which does not occur in iSPNs, is directly associated with motor abnormalities.
In addition to dopaminergic afferents, serotonergic inputs from the medial and dorsal raphe nucleus (DRN) modulate the activity of SPNs, affecting striatal function and consequently behaviors, including motor and motivational goal-directed behavior (Mathur and Lovinger, 2012) . Serotonergic neurons of the DRN fire coincidently with the initiation and termination of selected voluntary movements, whereas reduction in DRN activity to baseline or below is associated with pauses in motor sequences (Fornal et al., 1996; Jacobs and Fornal, 1999) . The evidence that striatal serotonin (5-HT) influences action control is consistent with the dysfunction of the 5-HT system described in OCD and with the use of selective serotonin reuptake inhibitors (SSRIs) for treatment of this disorder (Goddard et al., 2008) .
In the DS, 5-HT acts on diverse receptors on both presynaptic and postsynaptic circuit elements (Mathur and Lovinger, 2012) .
Depending on their localization, striatal 5-HT receptors initiate transduction through several Gi/o-, Gq/11-, and Gs proteindependent and -independent pathways (Hannon and Hoyer, 2008) . The specific responses to 5-HT may also be contingent upon crosstalk with other receptor types. In dSPNs, the temporal, combinational logic of serotonergic and D1R-mediated signaling may shape the net synaptic output, depending on the relative balance of these two neuromodulators. It has been reported that increased concentrations of 5-HT in the striatum reduce glutamate release at corticostriatal afferents by activating presynaptic Gi-coupled 5-HT1b receptors (Mathur et al., 2011) . 5-HT can also facilitate the release of DA from dopaminergic projections (Navailles and De Deurwaerdè re, 2011) . Despite their potential implications for BG function and for pathological conditions characterized by hypo-serotonergic states, the synaptic effects of reduced striatal 5-HT signaling remain unexplored. Neither is it known whether there is any input specificity for 5-HT modulation at corticostriatal and thalamostriatal synapses.
In the current study, we investigated the effect of impeding 5-HT release, and thereby serotonergic signaling, on timingdependent synaptic plasticity in dSPNs. This allowed us to describe cellular mechanisms underlying the input-specific impact of 5-HT at thalamostriatal synapses.
RESULTS

Chemogenetic Inhibition of 5-HT Release Gates t-LTD at Glutamatergic Afferents to dSPNs
To determine how plasticity is modulated at glutamatergic inputs on dSPNs of the dorsolateral striatum (DLS), we recorded excitatory postsynaptic potentials (EPSPs) following intrastriatal stimulation. Intrastriatal stimulation likely activates cortical and thalamic afferents as well as dopaminergic and serotonergic fibers ( Figure 1 ) (Shen et al., 2015; Threlfell et al., 2012; Wu et al., 2015) . dSPNs were selected through their negative resting membrane potential and firing properties (Kreitzer and Malenka, 2007; Nazzaro et al., 2012) . After recording, dSPN cell identity was confirmed by immunostaining for the specific marker substance P, and the lack of immunoreactivity for the iSPN marker A2A ( Figure 1A ) (Nazzaro et al., 2012; Trusel et al., 2015) .
We investigated long-lasting changes in EPSPs induced upon a spike-timing-dependent plasticity paradigm (STDP) (Shen et al., 2008) . As previously shown (Shen et al., 2008 (Shen et al., , 2015 , a post-pre STDP protocol ( Figure 1B) , in which the postsynaptic spike preceded the presynaptic stimulation, did not induce plasticity in this SPN subpopulation (96% ± 4% of baseline, n = 8, p > 0.05; Figure 1B ). Previous studies show that this STDP protocol leads to long-term synaptic depression (t-LTD) in dSPNs when either D1R is inhibited or striatal DA is depleted (Shen et al., 2008 (Shen et al., , 2015 . The effects of decreased 5-HT signaling at glutamatergic dSPN synapses during STDP remain to be determined, however.
To address the role of 5-HT, we manipulated its release chemogenetically. We used a newly generated transgenic DREADD (designer receptors exclusively activated by designer drugs) mouse line (hM4Di +/À /Pet1 210 -Cre) obtained by crossing the Pet1 210 -Cre transgenic mice (Pelosi et al., 2014 ) with hM4Di knockin mice expressing the DREADD hM4Di receptor (hM4DiR) fused in-frame with the mCherry reporter and flanked by two sets of Lox sites (i.e., LoxP/Lox2722) ( Figure S1A ). Upon Cre-mediated somatic recombination, the double-floxed DREADD sequence is effectively inverted, leading to transcription of the inhibitory hM4DiR in Pet1 210 -expressing 5-HT neurons. In brain slices from hM4Di +/À /Pet1 210 -Cre mice, these neurons and their projections can be identified by the expression of the mCherry reporter ( Figures S1B and S2A-S2L ). We first confirmed that the hM4DiR silenced serotonergic neurons of the DRN when activated by its cognate ligand clozapine-N-oxide (CNO; Figures S1C-S1F). Bath application of CNO (5 mM release from serotonergic terminals; the stimulatory effect of a second high K + challenge was blunted by the intrastriatal infusion of CNO (5 mM; p < 0.01; Figure S3B ). CNO did not affect K + -evoked release of 5-HT when infused in control mice (p > 0.05; Figure S3C ). These controls indicate that this model can be used to effectively silence the synaptic release of 5-HT in the DLS.
We assessed whether 5-HT synaptic silencing in the DLS affects plasticity outcomes by CNO application in hM4Di +/À / Pet1 210 -Cre mice (Figure 1 ). In dSPNs from these mice, t-LTD occurred in the presence of CNO, but not in the control (5 mM; 74% ± 4% of baseline, n = 8, p < 0.05 versus 95% ± 5% of baseline, n = 5, p > 0.05; Figure 1C ). There were no changes in synaptic responses when CNO was applied during a burst pattern of back propagating action potentials (bAPs) (94% ± 7% of baseline, n = 5, p > 0.05) or in the absence of the STDP protocol (93% ± 3% of baseline, n = 8, p > 0.05; Figure S4A ). Further, CNO had no effect when applied during the post-pre STDP paradigm in naive mice (92% ± 6% of baseline, n = 7, p > 0.05; Figure S4B) . These results indicate that the chemogenetic inhibition of 5-HT release in the DLS gates t-LTD at glutamatergic afferents to dSPNs.
Antagonism of 5-HT4R Signaling Enables t-LTD in dSPNs
Our findings indicate that 5-HT, similar to DA through the Gs-coupled D1R (Shen et al., 2008) , disrupts the induction of t-LTD in dSPNs. To elucidate the molecular mechanism underlying this role, we tested whether inhibiting 5-HT Gs-mediated signaling allows t-LTD to occur. The striatum contains a high density of the 5-HT6R and 5-HT4R subtypes, which, like D1R, are coupled to Gs and are expressed in SPNs (Di Matteo et al., 2008) . Bath perfusion of the 5-HT6R antagonist SB271046 (5 mM) during the post-pre protocol did not promote plasticity in dSPNs (99% ± 8% of baseline, n = 6, p > 0.05; Figure S4C ). In contrast, delivering the post-pre STDP paradigm in the presence of the 5-HT4R antagonists GR113808 (5 mM) or RS39604 (5 mM) revealed t-LTD in the same neuronal subpopulation (GR113808, 79% ± 5% of baseline, n = 8, p < 0.05; RS39604, 68% ± 4% of baseline, n = 10, p < 0.05; Figure 2A ). Thus, 5-HT4R inhibition recapitulates the synaptic effects of chemogenetic inhibition of 5-HT release. Application of either antag- /Pet1 210 -Cre mice, highlighting the 5-HT terminals (green) originating from the dorsal raphe nucleus (DRN). In DLS dSPNs from these mice, bath perfusion of CNO (5 mM; blue bar) during STDP gated a form of t-LTD, which was absent under control conditions (dSPN DREADD + CNO, n = 8, 7 mice; RM1WA F 7,44 = 8, p < 0.0001, p < 0.05 Tukey; dSPN DREADD , n = 5, 5 mice; RM1WA F 4,44 = 1.5, p = 0.3; dSPN DREADD + CNO versus dSPN DREADD , *p < 0.05, Mann-Whitney test). (B and C) In these figures, and in the analogous plots that follow throughout the manuscript, data are presented as a time course (mean ± SEM) of normalized EPSP amplitudes and normalized Rinp. Scatter plot summarizes the ratios of synaptic responses after (a) and before (b) the STDP, at the time points indicated. Insets represent superimposed averaged recordings (ten traces) before and after the delivery of the STDP protocol (vertical bar) onist in the absence of the pairing protocol did not affect glutamatergic synaptic transmission (GR113808, 94% ± 5% of baseline, n = 5, p > 0.05; RS39604, 96% ± 4% of baseline, n = 6, p > 0.05; Figure S4D ), confirming that coordinated postsynaptic and presynaptic activity is necessary for the induction of t-LTD.
Previous studies demonstrated that in dSPNs, antagonism of the Gs-coupled D1R signaling allows endocannabinoid (eCB) biosynthesis, ultimately leading to LTD mediated by activation of the presynaptic cannabinoid receptor CB1 (Shen et al., 2008 (Shen et al., , 2015 . However, this was not the putative mechanism for antagonism of 5-HT4R signaling, as the co-application of RS39604 with the CB1R antagonist AM251 (4 mM) did not prevent t-LTD induction (RS39604 + AM251, 62% ± 7% of baseline, n = 5, p < 0.05; Figure 2B ).
We next investigated the locus of plasticity expression by recording synaptic responses generated by twin stimuli, before (A) t-LTD was observed at glutamatergic dSPN synapses when the post-pre STDP protocol was delivered in the presence of the 5-HT4R antagonists GR113808 or RS39604 (5 mM; GR113808, n = 8, 7 mice; RM1WA F 7,44 = 7, p = 0.003, p < 0.05 Tukey; RS39604, n = 10, 9 mice; RM1WA F 9,44 = 14, p < 0.0001, p < 0.05 Tukey; 1WA F 2,23 = 10, p = 0.0008, dSPN+ GR113808 versus dSPN, *p < 0.05, dSPN+ RS39604 versus dSPN, ***p < 0.001; Tukey). The two 5-HT4R antagonists were applied throughout the entire duration of the recording. Solid black line (average) is the time course from Figure 1B , reported here for reference. (B) t-LTD gated by RS39604 was not blocked by the CB1R antagonist AM251 (4 mM; dSPN + RS39604/AM251, n = 5, 4 mice; RM1WA F 4,44 = 10 p = 0.001, p < 0.05 Tukey; dSPN + AM251/RS39604 versus dSPN + RS39604, p = 0.6, Mann-Whitney test). Solid green line (average) is t-LTD from (A) obtained in the presence of RS39604, reported here for reference. (C) t-LTD induced with the post-pre pairing upon application of RS39604 (5 mM) was not associated with changes in paired-pulse ratio (PPR). (Left) Plot shows the normalized first peak (p1) and second peak (p2) amplitudes of synaptic responses generated by twin stimuli at a 50 ms interval as a function of time (dSPN + RS39604, n = 6, 5 mice; p1, RM1WA F 5,44 = 5 p < 0.0001, p < 0.05 Tukey; p2, RM1WA F 5,44 = 6 p < 0.0001, p < 0.05 Tukey). (Right) Boxplot diagram indicates the PPRs of baseline (black box), and after STDP (red box) at the time points indicated (p = 0.5, paired t test). The values are the minimum, the median (bar inside the box), and the maximum. PPR is expressed as the ratio between the amplitude of the second and first EPSPs. (D) In the presence of RS39604, t-LTD was blocked by intracellular application of the endocytosis-disrupting peptides D15 (1.5 mM; dSPN + D15, n = 8, 8 mice; RM1WA F 7,44 = 1.7 p = 0.17) or GluA2 3Y (100 mg/ml; dSPN + GluA2 3Y , n = 6, 5 mice; RM1WA F 5,44 = 1 p = 0.4). The specificity of action of D15 and GluA2 3Y was confirmed by their respective control peptides (S15 for D15; GluA2 3A for GluA2 3Y ) (S15, 1.5 mM; dSPN + S15, n = 5, 3 mice; RM1WA F 4,44 = 4, p = 0.03, p < 0.05 Tukey; GluA2 3A , 100 mg/ml; dSPN + GluA2 3A , n = 6, 5 mice; RM1WA F 5,44 = 8, p = 0.0007, p < 0.05 Tukey; 1WA, F 4,28 = 7, p = 0.0004; dSPN + S15 versus dSPN, (legend continued on next page) and after the STDP protocol. In this set of experiments, we found that t-LTD was enabled by antagonism of 5-HT4R (RS39604, 77% ± 5% of baseline, n = 6, p < 0.05; Figure 2C ) but was not accompanied by a change in paired-pulse ratio (PPR), a hallmark of presynaptic plasticity (PPR, before STDP , 1.33 ± 0.09; after STDP , 1.36 ± 0.10, p > 0.05; Figure 2C ). This raises the possibility that this form of LTD is expressed postsynaptically. Consistent with this, intracellular dialysis of the peptide D15 (1.5 mM)-a peptide that prevents AMPAR endocytosis by disrupting the interaction between dynamin and amphiphysin (Carroll et al., 1999; Morishita et al., 2005 )-blocked t-LTD (D15/ RS39604, 91% ± 5% of baseline, n = 8, p > 0.05), whereas dialysis of a scramble peptide (S15, 1.5 mM) had no effect (S15/ RS39604, 63% ± 8% of baseline, n = 5, p < 0.05; Figure 2D ). The application in the postsynaptic neuron of the GluA2 3Y peptide (100 mg/ml), which blocks regulated, but not constitutive, AMPAR endocytosis (Brebner et al., 2005; Collingridge et al., 2010) , had a similar effect (GluA2 3Y /RS39604, 94% ± 3% of baseline, n = 6, p > 0.05; Figure 2D ). Confirming this peptide's specific action, the control peptide GluA2 3A (100 mg/ml) did not influence plasticity (GluA2 3A /RS39604, 70% ± 5% of baseline, n = 6, p < 0.05; Figure 2D ). Furthermore, variance analysis of synaptic responses indicated that t-LTD resulting from chemogenetic inhibition of 5-HT release (Figure 1 ) or application of 5-HT4R antagonists (Figure 2) is not accompanied by changes in trial-to-trial variation in EPSP amplitude ( Figure S4E ). This further supports a postsynaptic locus of plasticity expression (Shen et al., 2008) .
Overall, these data indicate that 5-HT controls plasticity induction in dSPNs through the activation of 5-HT4R; this effect is not mediated by eCBs, and it relies on postsynaptic expression mechanisms.
Serotonin Modulates bAP-Induced Ca 2+ Transients during STDP At glutamatergic synapses on SPNs, the induction of t-LTD depends on the temporal convergence of synaptic input and postsynaptic elevations of dendritic Ca 2+ signal triggered by (bAPs) (Plotkin et al., 2013; Shindou et al., 2011) . 5-HT has been shown to regulate ionic conductance that may affect the propagation of bAPs (King et al., 2008) . Modulation of the bAP-induced Ca 2+ signal may therefore be one of the mechanisms that affect timing-dependent synaptic plasticity in dSPNs (Plotkin et al., 2013; Shindou et al., 2011; Zhou et al., 2005) . To test this hypothesis, simultaneously with the chemogenetic and pharmacological inhibition of 5-HT signaling, we performed two-photon Ca 2+ imaging and whole-cell current clamp recordings and monitored changes in intracellular Ca 2+ . In the proximal dendrites of dSPNs, a single bout of the negative STDP protocol (1b-STDP) triggered Ca 2+ transients that were stable over time, as indicated by the lack of variation in the area under the curve (AUC) of the fluorescence transients over 10-15 min (106% ± 8% of control; n = 8, p > 0.05; Figure 3A ). In the dSPNs of hM4Di +/À /Pet1 210 -Cre mice, bath application of CNO (5 mM) to impede 5-HT release enhanced dendritic Ca 2+ influx in response to 1b-STDP (AUC, 130% ± 8% of control; n = 11, p < 0.01; Figure 3B) . The 1b-STDP-associated dendritic Ca 2+ signal increased upon application of the two 5-HT4R antagonists GR113808 (5 mM; AUC, 122% ± 6% of control; n = 15, p < 0.01; Figure 3C ) or RS39604 (5 mM; AUC, 130% ± 7% of control; n = 14, p < 0.01; Figure 3C ). Together, these results indicate that impeding 5-HT4R-mediated signaling boosts the bAP-induced dendritic Ca 2+ signal. These results appear to conflict with the notion that activation, not inhibition, of Gs-coupled receptors typically enhances voltage-gated Ca 2+ currents triggered by APs via stimulation of protein kinase A (PKA) (Higley and Sabatini, 2010) . In several neuronal subtypes, including striatal SPNs, inhibition of various types of K + currents that contribute to the AP repolarization, and after hyperpolarization phases, enhances dendritic Ca 2+ transients (Cai et al., 2004; Day et al., 2008; Trusel et al., 2015) . Therefore, we hypothesized that 5-HT4R regulates dendritic Ca 2+ levels by instead influencing the activity of K + channels. In addition to PKA, 5-HT4R can potentially signal to Ca 2+ / calmodulin-dependent protein kinase II (CaMKII) (Liu and Voyno-Yasenetskaya, 2005; Ponimaskin et al., 2002) , which positively regulates the activity of the large-conductance Ca 2+ -activated K + channel BK (Nelson et al., 2005; van Welie and du Lac, 2011) . To test if this is the case in dSPNs, we applied the BK channel blocker paxilline (10 mM) to isolate the BK-mediated current (as the paxilline-sensitive component, I Paxilline ) in response to a depolarizing voltage-ramp protocol ( Figure S5A ) (Deng et al., 2013) . The 5-HT4R agonist RS67333 (5 mM) significantly enhanced I paxilline amplitude (p < 0.05); this effect was prevented by the postsynaptic intracellular application of a specific competitive inhibitor of CaMKII, the autocamtide-2-related inhibitory peptide (AIP, 10 mM; p > 0.05; Figure S5B ). We also confirmed that stimulating 5-HT4R activates CaMKII in DLS dSPNs. On acute striatal slices from drd1a-tdTomato tg mice, which express Tomato in dSPNs (Shuen et al., 2008) , we monitored phosphorylation of CaMKII at Thr286 (pCaMKII). Incubation (10 min) with the 5-HT4R agonist RS67333 (5 mM) significantly increased the number of pCaMKII + /Tomato + cells compared to controls (p < 0.01; Figure S5C ). These data indicate that 5-HT4R can signal through CaMKII to positively modulate BK channel activity in dSPNs.
BK channels shape the duration of bAP in several neuronal populations and affect dendritic Ca 2+ influx (Golding et al., 1999) . Therefore, reduced release of 5-HT or direct inhibition of 5-HT4R could dampen the activation of BK channels during the STDP protocol, leading to an enhanced dendritic Ca 2+ signal in response to bAPs. To test this, we first assessed whether blocking BK channels occluded the effect of RS39604. Bath perfusion of paxilline (10 mM) significantly enhanced the **p < 0.01 ; dSPN + D15 versus dSPN, p = 0.9, dSPN + D15 versus dSPN + S15, *p < 0.05; dSPN + GluA2 3A versus dSPN, *p < 0.05; dSPN + GluA2 3Y versus dSPN, p = 1; dSPN + GluA2 3Y versus dSPN + GluA2 3A , *p < 0.05; Tukey). Solid black line (average) is the time-course from Figure 1B , reported here for reference.
(A-D) (Insets, left) In these figures, and throughout the manuscript, schematics depict proposed signaling pathway targeted by the defined drug, unless specified otherwise (see also Figure S4 ). 1b-STDP-associated Ca 2+ transient (AUC, 138% ± 7% of control; n = 9, p < 0.001; Figure 3D ). As predicted, sequential co-application of paxilline with RS39604 had no further effect on the induced change in dendritic fluorescence (AUC, 139% ± 7% of control; p < 0.001; 100% ± 3% of paxilline, p > 0.05; n = 9; Figure 3D ), suggesting that BK channels are targets of 5-HT4R signaling.
5-HT4R Modulates bAP-Induced Ca
2+ Signal through CaMKII Our 1b-STDP-stimulation protocol is likely to activate a set of glutamatergic, dopaminergic, and serotonergic inputs. Thus, it cannot isolate the impact of 5-HT4R on dendritic Ca 2+ influx specifically induced by bAPs. To overcome this issue, we estimated the Ca 2+ transients generated by somatically eliciting postsynaptic bAPs in the absence of presynaptic stimulation ( Figure 3E ). We replaced the contribution of 5-HT release on local electrical stimulation with the direct pharmacological stimulation of 5-HT4R by the agonist RS67333 (5 mM). Consistent with the hypothesis that 5-HT4R stimulates a K + channel conductance, the presence of RS67333 reduced the bAP-induced Ca 2+ signal (AUC, 71% ± 7% of control; n = 10, p < 0.01; Figure 3E ). Furthermore, blocking BK-mediated current prevented the effect of 5-HT4R stimulation: RS67333 failed to reduce the bAP-induced Ca 2+ transients upon pre-exposure to paxilline (AUC, paxilline, 142% ± 10% of control; p < 0.01; paxilline + RS67333, 142% ± 9% of control, p < 0.05; paxilline + RS67333, 101% ± 7% of paxilline, p > 0.05; n = 7; Figure 3F ). Further, the intracellular application of the CaMKII inhibitor AIP (10 mM) prevented RS67333 from reducing Ca 2+ transients elicited by bAPs (AUC, 105% ± 5% of AIP, p > 0.05; n = 10; Figure 3G ). The selective cell-permeable CaMKII inhibitor KN-62 (10 mM) had a similar effect: bath application boosted bAP-induced Ca 2+ transients ( Figure S5D ). This is consistent with bursts of bAPs activating CaMKII in proximal dendrites (Lee et al., 2009 ) and with CaMKII hindering the activation of BK channels recruited by bursts of bAPs, thus resulting in enhanced Ca 2+ transients. KN-62 prevented the inhibitory effect of RS67333 (AUC, KN-62, 155% ± 15% of control, p < 0.05; KN-62 + RS67333, 158% ± 22% of control, p < 0.05; KN-62 + RS67333, 99% ± 7% of KN-62, p > 0.05; n = 7; Figure S5D ), further supporting that CaMKII acts downstream of 5-HT4R to regulate bAP-induced Ca 2+ transients.
These results indicate that the modulatory effect of 5-HT4R activation involves CaMKII signaling. PKA may also act in the same pathway to shape bAP-induced Ca 2+ signal. Nevertheless, when the PKA inhibitor peptide 5-24 (20 mM) was intracellularly applied, RS67333 still reduced bAP-induced Ca 2+ signal (AUC, 83% ± 5% of PKI; p < 0.05, n = 7; Figure S5E ), suggesting PKA does not play a major role in this process. Overall, these data indicate that regulation of BK channel activity is required for the 5-HT4R-mediated modulation of dendritic Ca 2+ signal in dSPNs and that this modulation involves CaMKII signaling.
5-HT Signaling Controls t-LTD at Thalamic Inputs
We have demonstrated that 5-HT signaling, through the 5-HT4R subtype, influences the postsynaptic response of dSPNs to glutamatergic input activation during STDP. To dissect whether this modulation occurs at cortical and/or thalamic inputs, we probed the striatal circuitry with optogenetics. First, we used Thy1-ChR2 transgenic mice to measure postsynaptic responses evoked by light activation of corticostriatal afferents, which represent at least 50% of glutamatergic synapses on SPNs (Doig et al., 2010; Huerta-Ocampo et al., 2014) . In these mice, the expression of channel rhodopsin (ChR2) is high in cortical layer V neurons ( Figure 4A ) and appears not to extend to thalamostriatal neurons (Plotkin et al., 2014; Wu et al., 2015) . Short blue light pulses through the microscope objective (0.1-1 ms at 470 nm) elicits EPSPs in dSPNs (o-EPSP Ctx ). We investigated post-pre STDP at corticostriatal synapses by monitoring o-EPSP Ctx before and after the induction protocol. During the post-pre pairing paradigm, optogenetic stimulation of cortical inputs was replaced by conventional electrical stimulation in order to recruit 5-HT fibers ( Figure 4B ). In this experimental setting, the STDP protocol failed to induce significant changes in o-EPSP Ctx (98% ± 8% of baseline, n = 7, p > 0.05; Figure 4C ), even when applied in the presence of RS39604 (5 mM; 92% ± 6% of baseline, n = 8, p > 0.05; Figure 4C ). To corroborate this lack of involvement of corticostriatal synapses in a second model, we injected an adeno-associated viral (AAV) vector encoding ChR2-eYFP under the control of the CaMKIIa promoter [rAAV5-CaMKIIa-ChR2(H134R)-eYFP] into the M1 motor cortex region of C57BL/6J mice (Johnson et al., 2017 ) ( Figure S6A ). As with Thy1-ChR2 mice ( Figure 4C ), the STDP protocols failed to induce significant changes in dSPNs o-EPSP Ctx , regardless of the presence or absence of RS39604 (dSPN Ctx , 97% ± 6% of baseline, n = 7, p > 0.05; dSPN Ctx + RS39604, 90% ± 2% of baseline, n = 6, p > 0.05; dSPN Ctx versus dSPN Ctx + RS39604, p = 0.7 Mann Whitney test; Figures S6B and S6C ). Thus, corticostriatal synapses are not the primary target of the 5-HT4R-mediated effects at non-dissected glutamatergic inputs to dSPNs ( Figure 2A ). These results also suggest that gating of t-LTD due to decreased 5-HT signaling is in fact occurring at thalamostriatal inputs. To test this, we virally expressed ChR2 in the thalamus of C57BL/6J mice ( Figure 4D ) (Ellender et al., 2013; Johnson et al., 2017) and measured light-evoked EPSPs (o-EPSP Thal ) at thalamostriatal connections. To induce plasticity, we applied the same post-pre STDP paradigm described for corticostriatal synapses ( Figure 4B ). As predicted, the STDP protocol did not evoke plasticity of o-EPSP Thal in dSPNs under control conditions (103% ± 10% of baseline, n = 6, p > 0.05; Figure 4E ), whereas it triggered a significant t-LTD of o-EPSP Thal in the presence of RS39604 (5 mM; 71% ± 8% of baseline, n = 8, p < 0.05, Figure 4E ). We also controlled for the cell-type specificity of this effect. In iSPNs, the post-pre STDP paradigm already induced t-LTD of (A-G) (Right) Plot summary of modulation of dendritic Ca 2+ measured as area under the curve (AUC) of the fluorescence transients, in control conditions and with pharmacological manipulations, as indicated (A, B, and C, GR113808, n = 15, 10 mice; RS39604, n = 14, 11 mice; E, n = 10, 4 mice; G, n = 10, 4 mice; **p < 0.01, paired t test; D, n = 9, 5 mice; RM1WA, F 8,2 = 20 p < 0.0001, paxilline versus control, ***p < 0.001; paxilline + RS39604 versus control, ***p < 0.001; paxilline versus paxilline + RS39604, p = 1; Tukey; F, n = 7, 6 mice; RM1WA, F 6,2 = 9 p = 0.005, paxilline versus control, **p < 0.01; paxilline + RS67333 versus control, *p = 0.01, Tukey; paxilline versus paxilline + RS67333, p = 1; Tukey). (See also Figure S5 . ) o-EPSP Thal in control conditions (o-EPSP Thal , 67% ± 5% of baseline, n = 7, p < 0.05; Figures S7A and S7B) ; the application of RS39604 did not influence the plasticity outcome (o-EPSP Thal + RS39604, 68% ± 8% of baseline, n = 5, p < 0.05; Figure S7B ). We next assessed the link between the synaptic effects of 5-HT at thalamic inputs with the regulation of BK channel activity (Figure 3 ). In our model, decreased 5-HT signaling dampens the activation of BK channels during STDP and boosts the Ca 2+ signal induced by bAP (Figure 3 ). This mechanism could underlie the permissive role of 5-HT4R inhibition on t-LTD induction (Figures 2A and 4E) . If this is the case, we would expect the pharmacological inhibition of BK channels during conventional STDP to be sufficient to gate synaptic depression at thalamic inputs recruited by optogenetic activation. Reminiscent of 5-HT4R antagonism and chemogenetic inhibition of 5-HT release, in the presence of the BK channel blocker paxilline (10 mM), the STDP paradigm resulted in t-LTD of o-EPSP Thal (75% ± 4% of baseline, n = 7, p < 0.05; Figure S8A ).
The hM4Di +/À /Pet1 210 -Cre animals expressing ChR2 in the thalamus showed effects ( Figure 4F ) similar to those described above. The chemogenetic inhibition of 5-HT release by bath application of CNO (5 mM) during the post-pre STDP paradigm enabled t-LTD at thalamo-dSPN synapses (dSPN DREADD_Thal, 93% ± 1% of baseline, n = 7, p > 0.05; dSPN DREADD_Thal, + CNO, 61% ± 5% of baseline, n = 7, p < 0.05; Figure 4F ). Together, these results indicate that impeding serotonergic signaling, and in turn the activation of the 5-HT4R subtype, is sufficient to gate t-LTD at thalamostriatal synapses.
In addition to bAP-induced Ca 2+ transients, NMDA receptor activation is a possible means by which dendritic Ca 2+ signals could be enhanced to enable t-LTD at thalamostriatal synapses on dSPNs (Ellender et al., 2013; Wu et al., 2015) . However, the NMDAR antagonist R-CPP (10 mM) had no effect on o-EPSP Thal t-LTD gated by inhibition of BK channels during the post-pre STDP paradigm (dSPN Thal + Paxilline + R-CPP , 78% ± 6% of baseline, n = 7, p < 0.05; Figure S8A ) or by chemogenetic inhibition of 5-HT release in hM4Di +/À /Pet1 210 -Cre mice (dSPN DREADD_Thal, + CNO + R-CPP, 60% ± 7% of baseline, n = 5, p < 0.05; Figure S8B ). This indicates that NMDARs are not involved in this form of synaptic depression.
Lastly, we asked whether activating 5-HT4R signaling during the post-pre STDP paradigm is sufficient to disrupt t-LTD at thalamic inputs to dSPNs. We first tested the assumption that t-LTD at thalamo-dSPN synapses is suppressed by neuromodulatory signals (including 5-HT) released upon conventional electrical stimulation during STDP, as previously proposed (Wu et al., 2015) . We re-examined plasticity of o-EPSP Thal upon the delivery of an optogenetic post-pre pairing STDP protocol (o-STDP), which exclusively engages thalamic afferents. In this experimental setting, we observed a form of t-LTD at thalamo-dSPN synapses (72% ± 6% of baseline, n = 6, p < 0.05, Figure 5A ), consistent with previous observations (Ellender et al., 2013; Wu et al., 2015) . The 5-HT4R agonist RS67333 (5 mM) prevented t-LTD of o-EPSP Thal when applied during the o-STDP paradigm (91% ± 3% of baseline, n = 8, p < 0.05; Figure 5A ). We also injected the rAAV5-EF1a-DIO-hChR2(H134R)-eYFP virus into the DRN of Petl 210 -Cre mice to exert an optogenetic control of 5-HT release during plasticity induction ( Figure 5B ). In oblique horizontal slices from these mice, we electrically elicited thalamic synaptic responses in the DLS (e-EPSP Thal ) by placing the stimulating electrode in the thalamus, close to the border of the thalamic reticular nucleus ( Figure 5C ) (Ding et al., 2008 (Ding et al., , 2010 . Consistent with the response to the o-STDP paradigm ( Figure 5A ), e-EPSP Thal showed t-LTD upon a post-pre STDP paradigm in which thalamic axons were stimulated (Thal-STDP) (61% ± 7% of baseline, n = 6, p < 0.05; Figures 5C and  5D ). Optogenetically evoking 5-HT release at the time of presynaptic stimulation during pairing prevented t-LTD of e-EPSP Thal (93% ± 5% of baseline, n = 8, p > 0.05); plasticity was rescued by the application of RS39604 (5 mM; 44% ± 7% of baseline, n = 5, p < 0.05; Figures 5C and 5D ). This also indicates that t-LTD suppression is not due to light-induced release of glutamate from DRN terminals.
Collectively, these results further support the involvement of the 5-HT4R subtype in the 5-HT-mediated modulation of t-LTD at thalamic inputs on dSPNs.
5-HT4R Preferentially Localizes at Thalamostriatal Synapses
To increase certainty of the input specificity of the 5-HT4R mediated effects, we combined immunohistochemistry with three-dimensional (3D) segmentation and morphometric analysis of glutamatergic DLS synapses (Figures 6,  S9A , and S9B). We initially monitored the expression of 5-HT4R in two different mouse lines: the VGLUT1-Venus knockin line, which expresses the VGLUT1 transporter fused to the YFPvariant Venus and which allows direct visualization of axonal boutons from cortical afferents Herzog et al., 2011; Smith et al., 2014) , and the VGLUT2-Cre transgenic mice injected in the thalamus with the AAVrh9-pCAG-flex-eGFP-WRPE virus (AAV-FLEX-eGFP), to visualize thalamic inputs to the striatum. In this second mouse line, thalamic boutons were identified by immunolabeling for the presynaptic marker Bassoon (S€ udhof, 2012) . We measured the 3D edge-to-edge minimal distance from VGLUT1-positive cortical boutons and VGLUT2-positive thalamic boutons to the closest 5-HT4R. Although there was a higher density of VGLUT1 boutons, the distance between VGLUT1 boutons and 5-HT4R was significantly greater than between VGLUT2 boutons and 5-HT4R (VGLUT1-5-HT4R, 608 ± 26 nm; VGLUT2-5-HT4R, 364 ± 19 nm, p < 0.0001; with 19.34% ± 1.23% of VGLUT2 co-localizing with 5-HT4R and 9.81% ± 0.74% of VGLUT1 co-localizing with 5-HT4R; Figure 6A ). These morphological data support our functional observations showing that thalamostriatal synapses are the primary site of 5-HT4R-mediated effects (Figure 4) .
We then investigated the postsynaptic subcellular localization of 5-HT4R in dSPNs. The viral construct AAVrh9-PPTA-Cre (AAV-PPTA-Cre), which contains an expression cassette consisting of Cre recombinase driven by the dSPN-specific promoter of the PPTA gene (substance P), and the AAVrh9-pCAG-flextdTomato-WRPE (AAV-FLEX-tdTOMATO) construct expressing ''flexed'' tdTomato (Dos Hikida et al., 2010; Yagishita et al., 2014) were co-injected into the DLS. In dSPNs, we measured the number of co-localizing 5-HT4Rs in 3D-reconstructed dendrites and segmented headspines. 5-HT4R localization is predominant in the shaft, with 3.2 ± 0.5 5-HT4R per 10 mm of dendritic length ( Figure 6B ). To selectively visualize thalamic terminals on dSPNs, we analyzed VGLUT2-Cre mice co-injected with the AAV-FLEX-eGFP virus in the thalamus and with the AAV-PPTA-Cre and the AAV-FLEX-dtTOMATO viruses in the DLS. This analysis confirmed the postsynaptic subcellular localization of 5-HT4R in both axo-spinous and axo-dendritic thalamostriatal synapses ( Figure 6C ).
DISCUSSION
The results presented here reveal a previously unknown role of 5-HT at striatal circuits. This is the first demonstration that signaling by 5-HT receptors provides a control mechanism of Hebbian plasticity (t-LTD) at thalamo-SPN synapses of the direct pathway. These synaptic effects of 5-HT are mediated by the postsynaptic 5-HT4R subtype, which shapes bAP-evoked dendritic Ca 2+ signals through the regulation of BK channel activity and which is preferentially localized at axo-dendritic thalamostriatal synapses. Our findings help elucidate the full complement of 5-HT actions in the DS. Previous observations have shown that In dSPNs, t-LTD of e-EPSP Thal (dSPN e-Thal , n = 6, 6 mice; RM1WA F 5,44 = 4, p < 0.0001, p < 0.05 Tukey) was suppressed by light-induced 5-HT release (dSPN e-Thal + 5-HT opto , n = 8, 6 mice; RM1WA F 7,44 = 0.8, p = 0.9), and rescued by application of the 5-HT4R antagonist RS39604 (5 mM, dSPN e-Thal + 5-HT opto + RS39604, n = 5, 4 mice; RM1WA F 4,44 = 18, p = 0.0003, p < 0.05 Tukey; 1WA, F 2,16 = 16, p = 0.0002; dSPN e-Thal versus dSPN e-Thal + 5-HT opto , **p < 0.01; dSPN e-Thal versus dSPN e-Thal + 5-HT opto + RS39604, p = 0.2; dSPN e-Thal + 5-HT opto versus dSPN e-Thal + 5-HT opto + RS39604, ***p < 0.001; Tukey). increasing 5-HT levels in the DLS reduces presynaptic glutamate release and depresses neurotransmission at corticostriatal inputs through the activation of the presynaptic 5-HT1b receptor (Mathur et al., 2011) . Notably, 5-HT1b-mRNA is detectable in layer V cortical neurons, but not in the thalamic intralaminar nuclei (Allen Brain Atlas; http://www.brain-map.org/). In the current study, we find that impeding serotonergic signaling, thereby dampening the activation of the 5-HT4R subtype, affects postsynaptic dendritic Ca 2+ signals and gates spike-timing-dependent long-term depression (t-LTD) preferentially at thalamic afferents to dSPNs. Results presented in this study and by Mathur et al. (2011) highlight the complexity of striatal 5-HT signaling, which acts through diverse receptors at both presynaptic and postsynaptic sites (Mathur and Lovinger, 2012) and which may show specific subcellular compartmentalization. Here, we provide evidence that 5-HT4Rs are enriched at thalamostriatal synapses compared to cortical ones, and primarily localize at the dendritic shaft. Exogenously applied 5-HT or inhibition of 5-HT reuptake depresses corticostriatal afferents, whereas decreased synaptic release of 5-HT during STDP gates t-LTD at thalamostriatal inputs, suggesting that the net synaptic effect of 5-HT likely depends on its spatiotemporal dynamic in response to different patterns of stimulation. This may ultimately lead to spatiotemporal specificity of synaptic plasticity at defined inputs (i.e., cortical and thalamic inputs).
Upon impeding 5-HT signaling, t-LTD at undissected glutamatergic inputs is of an only slightly lower magnitude than that at thalamostriatal inputs recruited by optogenetic activation. These results appear to be at odds with the notion that at least 50% of excitatory inputs to SPNs are from the cortex (Doig et al., 2010 ; Huerta-Ocampo et al., 2014) and our current finding that inhibiting 5-HT4R does not gate plasticity at corticostriatal synapses. Indeed, one might predict that the magnitude of LTD recorded during electrical stimulation experiments would be algebraically diluted by unaffected cortical synapses. This prediction would require the plasticity at cortical and thalamic inputs to be independent. However, we cannot exclude the possibility that the Ca 2+ influx at cortical synapses that respond to electrical stimulation might influence thalamic synapses during the postpre STDP. Although cortical synapses do not experience t-LTD upon 5-HT4R inhibition, Ca 2+ -activated signaling molecules might diffuse from cortical spines to the dendritic shaft (Tang and Yasuda, 2017) , where 5-HT4Rs strongly co-localize with thalamic inputs (this study). This might affect local dendritic spikes and facilitate cooperative plasticity at thalamostriatal synapses (Golding et al., 2002; Popescu et al., 2007) . An alternative scenario is that electrical stimulation may activate unidentified inputs contributing to the EPSP that also experience LTD upon inhibition of 5-HT signaling; this form of plasticity might be independent of that occurring at thalamostriatal inputs. Our findings add to the limited knowledge of the intracellular signaling pathways regulating the thalamostriatal system, in particular the molecular mechanisms underlying synaptic depression of thalamo-dSPN synapses (Atwood et al., 2014; Ellender et al., 2011; Johnson et al., 2017; Parker et al., 2016; Wu et al., 2015) . t-LTD at thalamostriatal inputs has been shown to be independent of eCBs released from the postsynaptic SPN (Wu et al., 2015) . Consistent with this and with the evidence that thalamic afferents to the striatum are devoid of presynaptic CB1R (Wu et al., 2015) , we found that t-LTD gated by 5-HT4R antagonism is insensitive to CB1R inhibition and relies on postsynaptic expression mechanisms. In the DS, 5-HT4Rs are localized mainly postsynaptically (Di Matteo et al., 2008) . Activation of this Gs-coupled receptor subtype typically increases PKA activity and leads to the inhibition of K + channels (King et al., 2008) . Our findings point to an alternative signaling mechanism which involves CaMKII and activation of large-conductance BK channels. Indeed, 5-HT4R can couple not only with Gs proteins, but also with Ga13, which signals to CaMKII (Liu and Voyno-Yasenetskaya, 2005; Nelson et al., 2005; Ponimaskin et al., 2002) . In brain regions other than the striatum, CaMKII positively regulates BK channels (Nelson et al., 2005; Smith et al., 2002) . We found that the paxilline-sensitive, BK channel-mediated current was significantly increased upon 5-HT4R activation, and this enhancement was prevented by inhibition of CaMKII. The most parsimonious interpretation of these results is that 5-HT4R activation leads to CaMKII activation, which, in turn, increases the amplitude of the BK channel-mediated current.
The post-pre STDP protocol used in this study (intrastriatal stimulation) may be reminiscent of behavioral states in which the striatal release of 5-HT (and other neuromodulators) occurs concomitantly with coordinated post-and presynaptic activity. In post-pre STDP, the EPSP coincides with the afterhyperpolarization (AHP) that follows the bAP (Feldman, 2012) . Ultimately affecting bAP-induced Ca 2+ transients, AHP is shaped by the activity of Ca 2+ -activated K + conductances, including BK channels (Day et al., 2008) . We propose a model in which 5-HT positively modulates BK channel activity via stimulation of 5-HT4R during the post-pre STDP paradigm, ultimately reducing dendritic bAP-induced Ca 2+ influx (Figure 7 ). This may hinder the induction of t-LTD at thalamo-dSPN synapses, possibly by interfering with signaling pathways involved in the internalization of AMPAR (Grueter et al., 2010; L€ uscher et al., 2000) .
Conversely in this model, a decrease in 5-HT signaling during conventional post-pre STDP would dampen activation of BK channels and enhance bAP-induced Ca 2+ signaling, thus promoting AMPAR internalization and enabling t-LTD (Grueter et al., 2010; L€ uscher et al., 2000) (Figure 7 ). This could potentially mimic the circumstances in vivo, e.g., when post-pre STDP is uncorrelated to 5-HT release but occurs concomitantly with dopamine release or when there are pathological conditions characterized by hypofunctioning of the serotonergic system. Although our findings do not establish the precise identity of the thalamic afferents that are modulated by 5-HT, only thalamic inputs from the parafascicular thalamic (Pf) nucleus, and not from the central lateral (CL) nucleus, have been shown to express t-LTD (Ellender et al., 2013) . Notably, Pf nucleus projections are the primarily source for axo-dendritic synapses on SPNs (Smith et al., 2014) , where we found 5-HT4R to primarily localize, at least on dSPNs.
The 5-HT-mediated regulation of dendritic Ca 2+ signaling during STDP represents a means by which changes in serotonergic levels may shape the thalamostriatal system. Projections of the intralaminar nuclei of the thalamus to the striatum are critical to interrupt ongoing motor behavior and redirect attention toward salient stimuli ( Thorn and Graybiel, 2010) , or to encoding A-O contingencies (Bradfield et al., 2013a (Bradfield et al., , 2013b . Therefore, gating mechanisms of t-LTD at thalamic inputs that depend on serotonergic levels may affect the BG network and striatal information processing. Investigating the behavioral impact of 5-HT signaling specifically through the 5-HT4R subtype, as well as establishing synaptic causalities with modulation of thalamostriatal inputs, is certaintly an area for future studies.
Our results indicate that 5-HT at thalamic inputs, via 5-HT4R, exerts a similar function as DA at cortical inputs, via D1R (Shen et al., 2008) ; both signaling pathways contribute to the activation of dSPNs by increasing the strength of glutamatergic inputs. The fact that the activation of D1R by DA released during intrastriatal stimulation (Shen et al., 2015; Threlfell et al., 2012; Wu et al., 2015) cannot compensate for the decrease in Gs signaling when 5-HT4Rs are blocked suggests that D1R and 5-HT4R may be localized in the different functional microdomains. Further studies are required to assess whether D1Rs segregate at cortical spines. Regardless, morphologically, 5-HT4Rs are predominately localized at axo-dendritic rather than axo-spinous synapses. Since only thalamic inputs, but not cortical afferents, form axo-dendritic synapses, this subcellular postsynaptic localization of 5-HT4R (Figure 6 ) is consistent with the effects of 5-HT being specific to thalamic inputs. Building on existing models of striatal plasticity, we may now recognize excitatory DA and 5-HT as two complementary neuromodulatory systems controlling timing-dependent plasticity at two different glutamatergic inputs to dSPNs. This might allow for greater selectivity in tuning the activity of the direct pathway, which supports reinforcement and reward (Fisher et al., 2017; Kravitz et al., 2012) .
Overall, the findings from this study not only provide mechanistic insights into the thalamic control of striatal functions, but they also identify synaptic substrates for maladaptive plasticity in BG disorders that involve dysfunction of the serotonergic system.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS Animals
All procedures involving animals were carried out in accordance with the Italian Ministry of Health's directives (D.lgs 26/2014) regulating animal research. Animal experiments were designed in accordance with the ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines (Kilkenny et al., 2010) , with a commitment to refinement, reduction, and replacement, minimizing the number of mice. Drug, and test naive male mice at postnatal day 35-80 were housed 4-5 per cage in a temperature-and humidity-controlled room under a 12:12 h light/dark cycle with lights on at 07:00, and fed regular laboratory chow with ad libitum access to water. The following mouse strains were used in this study: C57BL/6J (Charles River Laboratories; RRID: IMSR_JAX:000664), hM4Di 
METHOD DETAILS
Generation of the hM4Di knockin mouse line We generated the hM4Di DIO conditional knockin mouse line taking advantage of a gene targeting strategy allowing the insertion of the construct via homologous recombination within the ROSA26 genomic locus. The in-frame fusion protein resulting from the hM4Di DREADD receptor and the mCherry reporter coding sequences was flanked by two couples of Lox sites (LoxP/Lox2722). The resulting cassette was isolated from the pAAV-hSyn-DIO-hM4Di/mCherry vector and cloned in the 3 0 -5 0 orientation within the pCX-CAGeGFP plasmid downstream of the CAG promoter by replacing the eGFP sequence. Subsequently, the CAG-hM4Di/mCherry fragment was isolated from pCX-CAG-hM4Di/mCherry via SpeI/XbaI double digestion and cloned in the XbaI site of the pROSA26-1 Sor plasmid that had been previously modified by the addition of a PvuI recognition site downstream to the pgk-DTa cassette in place of the unique XhoI site. Finally, the SpeI/NheI fragment containing the pgk-Neo/Kana cassette was obtained from the pPSVKeoFRT plasmid and cloned into the unique XbaI site of the pROSA26-1 Sor -CAG-hM4Di/mCherry vector. PvuI-linearized targeting vector was electroporated into E14Tg2a.4 ES cells and G418 selection was maintained for 7 days as described (Giorgi et al., 2017) . Among 192 G418-resistant ES cell colonies screened, 32 were positive recombinant clones as assessed by Southern blot analysis. Following karyotype analysis, recombinant ES cells were microinjected into C57BL/6J host blastocysts that were later reimplanted into pseudopregnant CD1 females. Germline transmission was achieved for the 60% of the 29 chimeras obtained. hM4Di DIO mice were born at normal Mendelian ratios and lived a normal lifespan with no obvious defects.
Animals were genotyped using DNA primers as follows: wild-type ROSA26 allele forward 5 0 -GAGGGGAGTGTTGCAATACC-3 0 and reverse 5 0 -AGTCTAACTCGCGACACTGTA-3 0 . The hM4Di DIO knockin allele was genotyped using the same forward primer as above in combination with the reverse primer 5 0 -GTCCCTATTGGCGTTACTATG-3 0 .
In vivo brain microdialysis hM4Di
+/À at 32 C, slices were kept at 22-24 C. During experiments, slices were continuously superfused with aCSF at a rate of 2 ml/min at 28 C. Electrophysiological recordings Whole-cell patch-clamp recordings were made on striatal projection neurons (SPNs) of the dorsolateral striatum (DLS) in horizontal or para-horizontal slices, or in neurons of the dorsal raphe nucleus (DRN) in coronal slices. Intracellular solution contained 130 mM KMeSO 4 , 5 mM KCl, 5 mM NaCl, 10 mM HEPES, 0.1 mM EGTA, 2 mM MgCl 2 , 0.05 mM CaCl 2 , 2 mM Na 2 -ATP and 0.4 mM Na 3 -GTP (pH 7.2-7.3, 280-290 mOsm/kg).
In the DLS, excitatory postsynaptic potentials (EPSPs) were induced at 0.1 Hz in the presence of the GABA A receptor antagonist gabazine (10 mM) by intrastriatal electrical stimulation using a concentric bipolar electrode (40-100 mA; 40-80 ms; FHC, Bowdoin, Maine) or by optogenetic stimulation of cortical or thalamic afferents using short blue light pulses (range 0.1-1 ms at 470 nm) of LED light delivered through the microscope objective (CoolLED, pE-100, Andover, Hampshire, United Kingdom). STDP-LTD was induced using a protocol consisting of 20 bouts of EPSPs paired with bAPs, delivered 10 s apart. Each bout consisted of five bursts (120 ms apart), each composed of three bAPs at 50 Hz followed by one EPSP (negative timing). The onset of the EPSPs followed the peak of the last postsynaptic action potential in the burst by 10 ms (Dt = 10 ms). During plasticity induction, postsynaptic neurons were depolarized from À80 mV to À70 mV. Data were excluded when the input resistance (R inp ) changed > 20%. In Pet1 210 -Cre mice expressing ChR2 in the DRN, thalamic afferents were stimulated by placing the stimulation electrode in the thalamus close to the border with the thalamic reticular nucleus. To induce the release of serotonin from DRN afferents in the DLS, blue light pulses (10 ms duration at 470 nm) of LED light were delivered through the microscope objective (CoolLED, pE-100, Andover, Hampshire, United Kingdom) at the time of presynaptic stimulation evoked during the STDP protocol. BK channel-mediated current was recorded in voltage-clamp configuration in response to a depolarizing voltage ramp from À80 to 110 mV (rate 0.1 mV/ms). Data are reported without corrections for liquid junction potentials. Data were acquired using a Multiclamp 700B amplifier controlled by pClamp 10 software (Molecular Device), filtered at 2.5 kHz and sampled at 10 kHz (voltage clamp), or filtered at 10 kHz and sampled at 20 kHz (current-clamp) with a (Digidata 1322, Molecular Device). For statistical purposes (RM2WA analysis; Figure S5B ), data were filtered at 0.1 kHz.
Imaging Ca 2+ transients were imaged with 100 mM Fluo-4 (ThermoFisher Scientific, Carlsbad, California) dissolved in the intracellular recording solution. Alexa 568 (10 mM, ThermoFisher Scientific, Carlsbad, California) was used for visualization of cell bodies and dendrites. SPNs were filled with Alexa 568 and Fluo-4 via the patch electrode for 20 min before imaging to allow dye equilibration in the proximal dendrites. Whole-cell maximum-projection images of the soma and dendrites were acquired with 0.4 mm 2 pixels with 15 ms pixel dwell time; $120 images were taken with 0.4 mm focal steps. Drugs were bath applied for 10 min. Two-photon Ca 2+ imaging was performed with a Leica SP5 AOBS upright DM6000 CFS microscope coupled with a 2P laser Chameleon Ultra Coherent and equipped with a Leica 25x NA 0.95 water immersion objective. The fluorescence emission was collected with an external non-descanned photomultiplier detector equipped with a 525/50 emission filter. Green fluorescence line-scan signals were acquired at 6 ms and 256 pixels per line, with 0.1 mm pixels and 20 ms pixel dwell time. The laser-scanned images were acquired with 800 nm light pulsed at 90 MHz (pulse duration: $250 fs). The line scan was used to record the fluorescence elicited by one bout of the STDP protocol. Images were collected with LAS AF Leica software and analyzed using ImageJ software (version 1.45, https://imagej.nih.gov/ij/, NIH, Maryland) and Origin 9.1 (OriginLab Corporation, Northampton, Massachussets). For each recording, background fluorescence was determined from a cell-free area of comparable size to that of the line-scan image. After subtracting the averaged background signal, fluorescence values were recorded for 200 ms before the triggering the STDP protocol and averaged to give the basal fluorescence (F basal ). The amplitude of the fluorescence transients at the recording sites was expressed as the fractional change in basal fluorescence, (F-F basal )/F basal, (DF/F), which is approximately proportional to the changes in intracellular Ca
2+
. Over the course of the experiment, F basal remained within the standard error of F basal measured under control conditions. For data analysis, transients were digitally filtered offline (adjacent-averaging routine, smoothing factor n = 5; Origin 9.1).
Immunofluorescence
Identification of dSPNs and iSPNs
To identify SPNs of the direct (dSPN) and indirect (iSPN) pathways, neurons were filled with Neurobiotin (0.5 mg/ml, Vector Laboratories,Peterborough, United Kingdom) during recordings and subsequently processed for immunostaining of the A2A receptor (marker of iSPNs) and substance P (marker of dSPNs) (Nazzaro et al., 2012; Trusel et al., 2015) . After recording, slices were fixed with 4% paraformaldehyde in 0.1 M phosphate buffer (0.1 M PB; pH 7.4) overnight at 4 C and then incubated in primary antibodies. Rabbit polyclonal antibody to A2A (1:250, Enzo Life Sciences, Farmingdale, New York) and rat monoclonal antibody to substance P (1:200, Millipore, Billerica, Massachussets) were diluted in 0.1 M PB containing 0.3% Triton X-100. Sections were subsequently incubated with Alexa 647-or Alexa 488-conjugated secondary antibodies (1:200) and Alexa 568-conjugated streptavidin (1:1000) (ThermoFisher Scientific, Carlsbad, California), mounted on glass slides, and coverslipped with ProLong Gold antifade reagent (ThermoFisher Scientific, Carlsbad, California). Images were acquired with an inverted Leica TCS SP5 AOBS TANDEM confocal microscope.
Immuno-EM analysis
Pre-embedding immuno-gold analyses were performed as described (Hebert-Chatelain et al., 2014) . In short, after a pre-incubation step in blocking solution [(10% BSA, 0.1% sodium azide and 0.02% saponin in Tris-buffered saline (TBS)], coronal sections were incubated with rat monoclonal anti-mCherry (1:50, Sigma Aldrich Italia, Milano, Italy) and rabbit polyclonal anti-5-HT (1:200, ThermoFisher Scientific, Waltham, Massachusetts, USA) primary antibodies in blocking solution with 0.004% saponin. After several washes (1% BSA in TBS), sections were incubated with a goat anti-rabbit biotinylated secondary antibody (1:150, Vector Laboratories, Peterborough, United Kingdom) and with secondary 1.4 nm gold-labeled goat anti-rat Immunoglobulin-G (Fab' fragment, 1:100, Nanoprobes Inc., Yaphank, New York, USA). Sections were then processed in avidin-biotin complex (1:50, Vector Laboratories, Peterborough, United Kingdom), silver-intensified with the HQ Silver kit (Nanoprobes Inc., Yaphank, New York, USA), and incubated in a solution of 0.05% DAB and 0.01% hydrogen peroxide (Vector Laboratories, Peterborough, United Kingdom). After post-fixation with 1% glutaraldehyde, the immunolabeled sections were analyzed by electron microscopy, as described (Giacomini et al., 2016) . Scanning transmission electron microscopy (STEM) images were collected with a Schottky field-emission gun FEI Tecnai G2 F20 (FEI, Hillsboro, Oregon) transmission electron microscope equipped with a high angular annular dark field (HAADF) detector and operating at an acceleration voltage of 200 kV.
Activation of CaMKII in acute slices
Acute slices from drd1a-tdTomato tg mice (n = 3) were prepared as described (Trusel et al., 2015) . After 1 h of recovery in aCSF at 32 C, slices were incubated 10 min at 32 C with or without 5 mM of the 5-HT4R agonist RS67333; after 5 min washout at 32 C in aCSF, slices were fixed in 4% PFA + 50 mM NaF for 4 h at 4 C. Slices were then rinsed three times (5 min each) in PBS and stored at À20 C in a cryoprotective solution (PBS + 30% glycerol + 30% PEG) until immunofluorescence was performed. After several washes in PBS, slices were permeabilized in PBS + 0.5% Triton X-100 for 4 h at room temperature, blocked with PBS + 0.5% Triton X-100 + 3% BSA for 1 h at room temperature and incubated with the primary antibody [rabbit anti-pCaMKII (Thr286) 1:400, Cell Signaling] in PBS + 0.1% Triton X-100 + 3% BSA overnight at 4 C. After several washes in PBS, slices were incubated with the secondary antibody (Alexa 488 anti-rabbit, 1:500, ThermoFisher Scientific) in PBS + 0.1% Triton X-100 + 3% BSA for 2 h at room temperature. After several washes in PBS, slices were mounted in ProLong Gold. Images were acquired with an inverted confocal microscope (Leica TCS SP5 AOBS TANDEM) with a 20X objective, acquiring 10 mm thick stacks with a 2 mm z-step, starting from 30 mm below the surface of the slice. For each experimental condition, 3 slices were acquired, and 2 images per slice were analyzed, counting the total number of pCaMKII and tdTomato double-positive cells.
QUANTIFICATION AND STATISTICAL ANALYSIS
Appropriate parametric statistic were utilized to test our hypothesis, unless data did not meet the assumptions of the intended parametric test (normality test). In this case, appropriate non-parametric test were used. Power analysis assumptions were: power = 0.9; alpha = 0.5; two-tailed and expected difference 50% greater than the observed standard deviation. Data were analyzed by two-way repeated-measure (RM2WA) or one-way repeated-measures ANOVA (RM1WA) for comparisons within a group, and one-way ANOVA (1WA) for between-group comparisons (GraphPad Prism 6 software). Post hoc analysis (Tukey; Home-Sidak, as indicated) was performed only when ANOVA yielded a significant main effect. Two groups were tested for statistical significance using the twopopulation t test and Mann-Whitney U-nonparametric test (GraphPad Prism 6 software). Statistical details of experiments are shown in results, figures and figure legends. Data are reported as mean ± s.e.m., unless stated otherwise. In the electrophysiological experiments, measurement of EPSPs were made using pClamp software (Molecular Devices). The occurrence and magnitude of synaptic plasticity was evaluated by comparing the normalized EPSP amplitudes from the last 5 min of baseline recordings with the corresponding values at 25-35 min after STDP (as indicated in Figure 1B ). LTD plots were generated by averaging the peak amplitude of individual EPSPs in 1 min bins. Coefficients of variation (CV) for EPSPs were calculated by the ratio of the standard deviation (sd) and the mean EPSP amplitude (Shen et al., 2008) . In imaging experiments, the magnitude of the Ca 2+ signal was measured as the area under the curve (AUC) in the transient region. n values for electrophysiological and imaging experiments represent the number of recorded cells. No statistical methods were used to pre-determine sample sizes, which were, however, similar to those reported previously (Nazzaro et al., 2012; Trusel et al., 2015) . For immunohistochemistry, images were processed with Adobe Photoshop (Adobe Systems) using only linear adjustments of contrast and color. 
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